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Abstract The adenovirus (Ad) genome complexed with viral
core proteins designated Ad core is the template for transcrip-
tion of early genes and the ¢rst round of replication in Ad-
infected cells. A cellular protein designated template-activating
factor-I (TAF-I) is found to be involved in remodeling of the Ad
core in vitro. Here we found that TAF-I interacts with the Ad
DNA through core protein VII in infected cells in early phases
of infection. In vitro binding assays using recombinant proteins
showed that TAF-I forms ternary complexes with DNA^protein
VII complexes.
% 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The adenovirus (Ad) genome DNA of about 36 000 bp is
condensed in the virion with viral basic proteins, core proteins
V and VII, and polypeptide X, forming a chromatin-like
structure. Protein VII with a molecular mass of 19 kDa is a
major DNA binding protein of the Ad genome^protein com-
plexes and has limited amino acid sequence homology with
histone H3 and a sperm basic protein [1]. Protein V forms an
outer shell around the Ad DNA^protein VII complex and
associates more loosely with Ad DNA than protein VII
[2,3]. Polypeptide X, a small highly basic peptide of 19 amino
acids, is suggested to play a role in the Ad DNA condensation
[4,5]. Protein VII and polypeptide X are synthesized as pre-
cursors, whereas protein V is as itself. Ad virions are uncoated
stepwise in the cytoplasm. The Ad genome^protein complex is
bound to nuclear pore complexes [6], and then imported into
the nucleus through nuclear pore complexes [7]. Protein V is
dissociated from the Ad genome during or right after its nu-
clear import, while protein VII remains associated with the
Ad DNA throughout early phases of infection [8,9]. This nu-
cleoprotein complex composed of the Ad genome DNA and
protein VII, here designated Ad core, is a bona ¢de template
for transcription of immediate-early and early viral genes and
the ¢rst round of DNA replication.
We have identi¢ed template-activating factor-I (TAF-I)/
SET [10^12], TAF-II/NAP-1 [13,14] and TAF-III/nucleo-
phosmin/B23 [14] from uninfected HeLa cell extracts as stim-
ulatory factors in cell-free Ad DNA replication and transcrip-
tion systems using the Ad core as template. It is shown that
TAF-I binds to the Ad core in vitro and enhances the nucle-
ase sensitivity of the Ad core [15]. Therefore, it is suggested
that TAF-I remodels the Ad core by forming a ternary com-
plex composed of DNA, core proteins and TAF-I, thereby
making the replication and transcription machineries accessi-
ble to DNA. However, the exact mechanism of remodeling of
the Ad core by these factors has not been well elucidated.
Studying detailed mechanisms would shed light on the molec-
ular mechanism of remodeling of the cellular chromatin by
these proteins, since TAF-I, -II and -III are found to function
as histone chaperones [14^16].
In this report, we ¢rst showed that TAF-I interacts with the
Ad DNA through protein VII in early phases of infection in
infected cells. Furthermore, we analyzed the binding mode of
TAF-I to protein VII and protein VII^DNA complexes using
recombinant proteins. These analyses have revealed that
TAF-I is capable of forming stoichiometric ternary complexes
with the Ad DNA^VII complex.
2. Materials and methods
2.1. Protein preparation
The gene corresponding to the precursor of protein VII (pre-VII)
was ampli¢ed by polymerase chain reaction (PCR) from the human
adenovirus type 5 (HAdV-5) genomic DNA using a set of primers, 5P-
GCCTCGAGATGTCCATCCTTATATCGCCC-3P and 5P-GCCTC-
GAGCTAGTTGCGCGGGGGGCGGG-3P. Nucleotide sequences
were con¢rmed by sequencing the DNA. PCR products were digested
with XhoI, and cloned into the XhoI site of plasmid pET14b (Nova-
gen) for expression in Escherichia coli of a pre-VII tagged with amino-
terminal hexahistidines (His-pre-VII). His-pre-VII was expressed in
the E. coli strain BL21(DE3) in LB medium containing 0.1 mg/ml
ampicillin by the addition of isopropyl-L-D-thiogalactopyranoside at
a ¢nal concentration of 0.2 mg/ml. The cells were disrupted by son-
ication, and an insoluble fraction containing His-pre-VII was recov-
ered by centrifugation. His-pre-VII was solubilized with 6 M urea and
puri¢ed through a Ni-NTA (Novagen) column in the presence of 6 M
urea according to the manufacturer’s instruction. Puri¢ed His-pre-VII
was dialyzed against water, and then subjected to lyophilization. His-
pre-VII was dissolved in bu¡er A (20 mM Tris^HCl pH7.9, 0.5 M
NaCl and 6 M urea) and further puri¢ed through HiPrep Sephacryl
S-200 column chromatography (Amersham Biosciences). Puri¢ed His-
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pre-VII was dialyzed against water and stored at 330‡C until use.
Protein VII was prepared by digestion of His-pre-VII with Ad pro-
tease in the condition as previously described [17^19]. His-pre-VII was
digested at 37‡C for 6 h in a mixture containing 0.5 mg/ml His-pre-
VII, 0.5 mg/ml salmon sperm DNA, 50 WM polypeptide VIc, a pro-
tease activator peptide NH2-GVWSLKRRCF-COOH, and 10 Wg/ml
hexahistidine-tagged Ad protease (His-Ad protease), 20 mM Tris^HCl
pH 7.9. Then, the concentrations of NaCl and urea were adjusted to
0.5 M and 6 M, respectively. The mixture was loaded on a UnoS
column (Bio-Rad), and protein VII was eluted with 20 ml of a linear
gradient of 0.5^1.5 M NaCl in bu¡er A. Puri¢ed protein VII was
dialyzed against water and stored at 330‡C until use. Polypeptide
VIc [17] was synthesized by the Fmoc method and puri¢ed by high
performance liquid chromatography. Recombinant His-Ad protease
was prepared as follows: the open reading frame (ORF) of the Ad
protease was cloned from HAdV-2 by PCR and inserted into pQE9
vector (Qiagen). E. coli M15 strain was transformed with the plasmid
DNA. His-Ad protease was expressed and puri¢ed as described for
His-TAF-I (see below). Recombinant human TAF-I with a hexahis-
tidine tag (His-TAF-I) at its amino-terminus was prepared as de-
scribed previously [11,20]. Recombinant (r) TAF-I without histidine
tag (rTAF-I) was prepared as follows: TAF-I ORF DNA fragment
was prepared by digestion of pET14b-TAF-I plasmid DNA with
BamHI and NdeI, and inserted into pET3a treated with the same
restriction enzymes. rTAF-I was expressed in E. coli strain
BL21(DE3). Cells were lysed by sonication in bu¡er B containing
20 mM Tris^HCl pH 7.9 and 0.2 M NaCl. rTAF-I recovered in a
soluble fraction was loaded on a DE52 (Whatman) column and eluted
with a linear gradient of 0.2^0.4 M NaCl in bu¡er B. rTAF-I was
puri¢ed through UnoQ column (Bio-Rad) chromatography. rTAF-I
was eluted with a linear gradient of 0.25^0.55 M NaCl in bu¡er B.
rTAF-I was further puri¢ed by a HiPrep Sephacryl S-200 column
chromatography and stored at 380‡C until use.
2.2. Antibodies
Rat polyclonal antiserum against pre-VII was generated by immu-
nization of a 5-week-old male rat (SD, Tokyo Jikkenn Doubutu) with
100 Wg His-pre-VII in Freund’s complete adjuvant (Sigma). The ani-
mal was boosted twice with 30 Wg and 50 Wg pre-VII in Freund’s
incomplete adjuvant, respectively, at 2-week intervals. Mouse mono-
clonal anti-TAF-IL antibody (KM1721) [21] was used for Western
blotting and immunoprecipitation.
2.3. Chromatin immunoprecipitation (ChIP) assay
ChIP assays were carried out according to the manual of the ChIP
assay kit (Upstate Biotechnology) with minor modi¢cations. HeLa
cells (1U106 cells) were infected with HAdV-5 at a multiplicity of
100 plaque-forming units (PFU)/cell. Hydroxyurea (HU) was added
at a ¢nal concentration of 3 mM at 2 h post infection (h.p.i.) when the
Ad DNA replication was to be blocked. At indicated time points after
infection, cells were cross-linked with formaldehyde at a ¢nal concen-
tration of 1% at room temperature for 10 min, followed by addition
of glycine at a concentration of 0.125 M. Cells were collected in a 1.5-
ml tube and lysed by sonication in 0.4 ml of sodium dodecyl sulfate
(SDS) lysis bu¡er (1% SDS, 10 mM EDTA, 50 mM Tris^HCl pH 7.9
and 1 mM phenylmethylsulfonyl £uoride (PMSF)). After centrifuga-
tion, a supernatant fraction was diluted 10-fold with ChIP dilution
bu¡er (16.7 mM Tris^HCl, pH 7.9, 167 mM NaCl, 1.2 mM EDTA,
1.1% Triton X-100, 0.01% SDS and 1 mM PMSF). The lysate was
pre-cleared by rotating with protein A-Sepharose beads pre-masked
with salmon sperm DNA (0.2 mg/ml) and bovine serum albumin (0.5
mg/ml) for 30 min. One-eighth volume of the lysate was incubated
with appropriate antibodies where indicated. After incubation with
pre-masked protein A-Sepharose beads for 30 min, immune com-
plexes were recovered. The beads were washed successively with
high-salt wash bu¡er (20 mM Tris^HCl pH 7.9, 2 mM EDTA, 500
mM NaCl, 1% Triton X-100 and 0.1% SDS), and LiCl wash bu¡er
(10 mM Tris^HCl pH 7.9, 1 mM EDTA, 0.25 M LiCl, 1% NP-40 and
1% deoxycholate). The beads were washed with TE (10 mM Tris^HCl
pH 7.9, 0.5 mM EDTA) and transferred to a new 1.5-ml tube. Pro-
teins were eluted with 0.2 ml of freshly prepared elution bu¡er (0.1 M
NaHCO3 and 1% SDS). Cross-linking was reversed by adding NaCl
at a ¢nal concentration of 0.2 M and incubation at 65‡C overnight.
After addition of Tris^HCl pH 6.5 (¢nal 40 mM) and EDTA (¢nal 10
mM), the eluate was treated with proteinase K. DNA was extracted
with phenol/chloroform, precipitated with ethanol, and dissolved in 50
Wl of TE. At the same time DNA was recovered from a portion of
pre-cleared lysates and designated input DNA. A target sequence was
detected by PCR with speci¢c primers where indicated. The PCR
products were separated by a 2% agarose gel and stained with
SYBR Gold (Molecular Probes).
2.4. Electrophoretic mobility shift assay
DNA fragments of 34 bp were prepared by digestion of pUC119
with MspI followed by puri¢cation of the DNA fragment excised
from polyacrylamide gel. Reconstitution of DNA^protein VII com-
plexes was performed in a bu¡er (total volume of 10 Wl) containing 40
mM Tris^HCl pH 7.9, 150 mM NaCl, 12.5% glycerol, 50 ng DNA
and 80 ng protein VII by incubation at 37‡C for 15 min. For ternary
complex formation, His-TAF-I was added to the DNA^protein VII
mixture and incubated at 37‡C for 15 min. The mixture was subjected
to a 7.5% polyacrylamide gel electrophoresis (PAGE) in 0.5UTBE
(Tris-borate/EDTA). After the electrophoresis, DNA was stained
with SYBR Gold (Molecular Probes) and visualized by FluoroImager
595 (Molecular Dynamics). For transfer of proteins in the polyacryl-
amide gel to a nitrocellulose membrane, a gel was immersed in the
SDS^PAGE electrophoresis bu¡er for 30 min and rinsed brie£y with a
transfer bu¡er (25 mM Tris^HCl, 192 mM glycine, pH 8.3). Proteins
were then transferred to a nitrocellulose membrane using a semi-dry
protein blotting apparatus (Bio-Rad). His-TAF-I was visualized with
enhanced chemiluminescent (ECL) reagent after serial incubation of
anti-TAF-I antibody, biotin-conjugated anti-mouse IgG and avidin-
conjugated horseradish peroxidase.
3. Results
3.1. In vivo interaction of TAF-I with adenovirus core
complexes
TAF-I was identi¢ed as a factor that stimulates replication
of the Ad core DNA in vitro [10]. Glycerol gradient analyses
using puri¢ed TAF-I and Ad cores showed that TAF-I is
bound to the Ad core [15]. Since TAF-I is incapable of bind-
ing to DNA, TAF-I would bind to the Ad core through core
proteins (see below). Here, to see whether TAF-I is associated
with the Ad core in Ad-infected cells, we tried to detect the
Ad DNA in complexes isolated by immunoprecipitation with
anti-TAF-I and anti-pre-VII antibodies (Fig. 1). To this end,
polyclonal anti-pre-VII antibody was generated, and the spec-
i¢city of this antibody was examined by Western blotting us-
ing recombinant His-pre-VII, protein VII, and extracts pre-
pared from uninfected and infected cells (Fig. 1A). This
antibody recognized both recombinant His-pre-VII and pro-
tein VII (lanes 1 and 2). Protein VII and pre-VII in extracts of
infected cells were speci¢cally recognized by this antibody
(lanes 3 and 4). HeLa cells were infected with HAdV-5 and
subjected to cross-linking with formaldehyde at 3, 6 and 12
h.p.i. (Fig. 1B) The cells were disrupted by extensive sonica-
tion, and cell lysates were subjected to immunoprecipitation.
The DNA associated with the immunoprecipitate was iso-
lated, and analyzed by PCR with a speci¢c primer set for
the major late gene (ML) ORF region of the Ad genome
DNA (for details see Fig. 4). Protein VII was associated
with the Ad DNA in early phases of infection (Fig. 1B, upper
panel, lanes 13 and 14). Furthermore, association of the Ad
DNA with TAF-I was also detected in early phases of infec-
tion (lanes 7 and 8). Thus, it is concluded that the Ad DNA is
associated with complexes containing TAF-I in Ad-infected
cells in early phases of infection. The amount of input Ad
DNA at 12 h.p.i. was more than that at 6 h.p.i. (lanes 2
and 3), suggesting that DNA replication initiates between 6
and 12 h.p.i. The amount of the Ad DNA associated with
TAF-I decreased slightly at 12 h.p.i. (lane 9). The Ad DNA
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associated with protein VII also decreased at 12 h.p.i. (lane
15). These observations suggest that TAF-I and protein VII
are dissociated from the Ad DNA during the progression of
infection. Essentially similar results were obtained with other
primer sets (data not shown). Note that protein VII is derived
from the incoming Ad core, since protein VII is synthesized as
a pre-VII in late phases of infection after the onset of DNA
replication [22]. To con¢rm that TAF-I is associated with the
Ad DNA before the onset of replication, immunoprecipitation
assays were performed using cell lysates prepared from cells
maintained in the presence of HU, a replication inhibitor (Fig.
1B, bottom panel). The amount of input DNA remains con-
stant up to 12 h.p.i. (lanes 1^3), indicating that replication is
inhibited. The amount of Ad DNA immunoprecipitated with
anti-TAF-I antibody at 3 and 6 h.p.i. in the presence of HU is
virtually the same as that in the absence of HU, indicating
that the Ad DNA interacts with TAF-I prior to the onset of
Ad DNA replication and the de novo synthesis of late pro-
teins including pre-VII. The amount of TAF-I-associated Ad
DNA and protein VII-associated Ad DNA decreased at 12
h.p.i. in the presence of HU, suggesting that TAF-I and pro-
tein VII are dissociated from the Ad DNA without replica-
tion.
3.2. Ternary complex formation of TAF-I with DNA^protein
VII complexes
It is presumed that TAF-I mediates remodeling of the Ad
core through forming a ternary complex composed of Ad
DNA^protein VII^TAF-I [15]. Here, we examined if such a
ternary complex can be formed in vitro using DNA, puri¢ed
recombinant protein VII and TAF-I proteins. We prepared
protein VII by processing puri¢ed His-pre-VII with Ad pro-
tease, since the expression level of a mature form of protein
VII in E. coli is quite low while that of His-pre-VII is high. In
addition, it is possible that the processing reaction may be
involved in formation of functional protein VII. Formation
of ternary complexes was monitored by an electrophoretic
mobility shift assay. Nucleoprotein complexes were ¢rst re-
constituted by mixing a 34-bp-long DNA and protein VII
(Fig. 2A, lanes 2). Under the experimental conditions, DNA
complexed with protein VII did not enter the gel, possibly due
to the assumption that highly basic protein VII irrespective of
the presence of DNA moves to the anode. After formation of
nucleoprotein complex, His-TAF-I was added to the mixture
and further incubated. The complexes retained in origin could
be aggregates. Addition of His-TAF-I to DNA^protein VII
complexes resulted in resumption of free DNA, suggesting
Fig. 1. Interaction of TAF-I with Ad DNA in infected cells. A: Polyclonal antibody directed against bacterially produced His-pre-VII. HeLa
cells were mock-infected (lane 3) or infected with HAdV-5 at a multiplicity of infection of 100 PFU (lane 4). Cells were harvested at 24 h.p.i.,
and cell extracts were prepared by sonication. These cell extracts, recombinant His-pre-VII (lane 1) and protein VII (lane 2), were subjected to
Western blotting analysis with anti-pre-VII antibody. Pre-VII and protein VII were transferred to a polyvinylidene di£uoride membrane in a
transfer bu¡er containing 0.05% SDS, while TAF-I was transferred in the absence of SDS. The proteins were visualized by incubation with bio-
tin-conjugated anti-rat IgG and avidin-conjugated alkaline phosphatase, and color was developed by addition of cleavable chromophore. Aster-
isks indicate background bands which appeared without ¢rst antibody (data not shown). B: ChIP assay. HeLa cells (1U106 cells) were infected
with CsCl-puri¢ed HAdV-5 as described previously [10] at a multiplicity of 100 PFU. HU was added at 2 h.p.i. (bottom panel). At 3 (lanes 1,
4, 7, 10 and 13), 6 (lanes 2, 5, 8, 11 and 14) and 12 h.p.i. (lanes 3, 6, 9, 12 and 15), the cells were cross-linked with formaldehyde and then col-
lected. Cell lysates prepared as described in Section 2 were subjected to immunoprecipitation with antibodies against TAF-I (lanes 7^9) and
protein VII (lanes 13^15). The same amount of mouse anti-£ag IgG antibody (Sigma) and the same volume of rat preimmune serum was used
as a control antibody for anti-TAF-I antibody (IgG) and anti-pre-VII antibody, respectively. Input lanes contain 0.4% of the input lysates used
for experiments shown in lanes 4^15. The DNA associated with immunoprecipitates was puri¢ed, and ampli¢ed semi-quantitatively using PCR
with a set of No. 5 primers indicated in Fig. 4A.
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that His-TAF-I remodels and disrupts DNA^protein VII
complexes including aggregates. His-TAF-I also facilitated
formation of distinct bands designated ‘complex 1’ and ‘com-
plex 2’ (lanes 3^6). Western blotting of the gel with the anti-
TAF-I antibody showed that His-TAF-I is present in four
bands, complex 1 and complex 2 (lanes 3^6), His-TAF-I^pro-
tein VII (lane 7), and His-TAF-I (lane 8), suggesting that
DNA^protein VII^His-TAF-I ternary complexes were formed
as complex 1 and complex 2 (see the merged panel).
The formation of the ternary complex of core proteins, a
long DNA (3.4 kb), and rTAF-I was further examined by
glycerol gradient assays (Fig. 2B). The nucleoprotein com-
plexes were subjected to a 10^40% glycerol gradient in the
presence of 150 mM NaCl. The amount of DNA in each
fraction collected from the top was quanti¢ed using dot blot
hybridization, and proteins in each fraction were separated on
a 12.5% SDS^PAGE and stained with Coomassie brilliant
blue. Free DNA in an independent centrifugation was recov-
ered in fractions 5^7, while both rTAF-I and protein VII free
of DNA were recovered in top fractions (data not shown).
When rTAF-I was added to DNA^protein VII complexes, a
portion of rTAF-I was recovered in fractions 9^11, where
both DNA and protein VII are present. These observations
together with the results shown in Fig. 2A strongly suggest the
formation of the DNA^protein VII^TAF-I ternary complex.
3.3. Stoichiometry of the TAF-I^protein VII binary complexes
In order to know the structural basis for the mechanism of
Ad core remodeling by TAF-I, the stoichiometry of the binary
complex composed of TAF-I and protein VII was examined
(Fig. 3). Mixtures of rTAF-I and protein VII were resolved by
a 7.5% native PAGE, and proteins were visualized by staining
with Coomassie brilliant blue (Fig. 3A). TAF-I is a dimeric
acidic protein [20] and migrated toward the anode (lane 1),
while protein VII is a highly basic protein and did not enter
the gel (lane 6). When rTAF-I and protein VII were mixed at
a molar ratio of 2:1 (one TAF-I dimer and one protein VII), a
band migrating more slowly than the band corresponding to
Fig. 2. Ternary complex formation of TAF-I with DNA^protein VII complexes. A: Electrophoretic mobility shift assay. Nucleoprotein com-
plexes of DNA^protein VII (lanes 2^6) were reconstituted at 37‡C for 15 min by mixing 34-bp-long DNA (50 ng= 2.2 pmol) with protein VII
(80 ng=4 pmol). The mixtures were further incubated in the absence (lane 2) and presence of His-TAF-I (4, 8, 16, 32 pmol for lanes 3, 4, 5
and 6, respectively). The samples were separated on a 7.5% polyacrylamide gel in 0.5UTBE bu¡er. DNA alone, a mixture of His-TAF-I and
protein VII (lane 7), and His-TAF-I alone (lane 8) were also analyzed. DNA was visualized by staining with SYBR Gold (left panel), while
His-TAF-I was detected by Western blotting using anti-TAF-I antibody (right panel). Images of left and right panels were merged (green,
DNA; red, TAF-I) with Adobe Photoshop 5.0 (middle panel). B: Glycerol density assay using reconstituted DNA^protein VII complexes and
rTAF-I. Nucleoprotein complexes of DNA^protein VII were reconstituted by mixing linearized plasmid DNA (3 Wg) of 3.4 kb with protein VII
(3 Wg= 150 pmol) at 37‡C for 15 min. DNA^protein VII complexes were further incubated with rTAF-I (6 Wg= 180 pmol) and subjected to
centrifugation at 15‡C for 4 h in a SW55 rotor (Beckman) at 45 000 rpm through a 10^40% glycerol gradient in 10 mM Tris^HCl pH 7.9, 0.5
mM EDTA and 150 mM NaCl. A portion (2%) of input proteins and proteins in fractions collected from the top were separated on a 12.5%
SDS^PAGE and visualized by staining with Coomassie brilliant blue. DNA in each fraction was dot-blotted and hybridized with [K-32P]dCTP-
radiolabeled probe prepared with Prime-It II Random Primer Labeling Kit (Stratagene). Almost all DNA^protein VII complexes without
rTAF-I sedimented and attached to the bottom wall designated ‘Ppt’ fraction (data not shown).
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the TAF-I dimer designated ‘complex A’ was detected (lanes 2
and 3). When the molar ratio was adjusted to 1:1 (one TAF-I
dimer and two protein VII), the other slowly migrating band
designated ‘complex B’ was detected (lane 4). Addition of
protein VII at a molar ratio more than 1:1 resulted in change
of the color of the solution to cloudy white, suggesting that
aggregation was formed (data not shown). The aggregates
may move to the cathode, so that no protein bands were
observed (lane 5). The stoichiometry was examined by mea-
suring the amount of each protein in complexes A and B. To
this end, the gel slices corresponding to complexes A and B
were excised, and proteins eluted from the gel slices were
separated by SDS^PAGE and visualized by staining with
Coomassie brilliant blue. These experiments showed that com-
plex A consists of 1.2 mol of TAF-I dimer and 1 mol of
protein VII, while complex B consists of 1.3 mol of TAF-I
dimer and 2 mol of protein VII (data not shown). The stoi-
chiometry was further con¢rmed by cross-linking assays (Fig.
3B). Aliquots of samples of Fig. 3A were cross-linked with a
chemical cross-linker, glutaraldehyde (GA). Proteins were sep-
arated by SDS^PAGE, and stained with Coomassie brilliant
blue. The apparent molecular mass of rTAF-I and protein VII
estimated by SDS^PAGE was 39 kDa and 26 kDa, respec-
tively ([10] and data not shown). The band of 78 kDa is a
dimeric form of rTAF-I as previously described (lane 1) [20].
Under conditions for formation of complex A (Fig. 3A, lane
3), and for formation of both complex A and complex B (Fig.
3A, lane 4), complex a and complex b with molecular masses
of 106 kDa and 130 kDa were observed (Fig. 3B, lanes 2 and
3). Based on the molecular mass, complex a and complex b
could be a complex of one dimeric form of rTAF-I and one
protein VII or a complex of one dimeric form of rTAF-I and
two protein VII, each corresponding to complex A and com-
plex B, respectively. Thus, it is concluded that 1 mol of TAF-I
dimer form complexes with either 1 or 2 mol of protein VII.
3.4. Localization of TAF-I on the Ad genome
We found the interaction of TAF-I with protein VII in
infected cells (Fig. 1) and con¢rmed the ternary complex for-
mation in vitro. Then, we tried to examine the sequence spec-
i¢city for localization of TAF-I and protein VII on the Ad
DNA using various primer sets (Fig. 4A) for ChIP-PCR (Fig.
4B). Three independent experimental results are summarized
in Fig. 4C. The histogram of the distribution of TAF-I and
protein VII on the Ad genome DNA showed that TAF-I is
not uniformly distributed within the Ad DNA (Fig. 4C). In
particular, the E1a promoter region was relatively free of
TAF-I (see Section 4). TAF-I was localized slightly less in
regions of E1b ORF, E3 ORF and E4 ORF than the other
regions. The distribution pattern of protein VII was correlated
to some degree with that of TAF-I. Since this result shows
that TAF-I is localized where protein VII is localized, it is
likely that there is no di¡erence in binding a⁄nity of TAF-I
to protein VII depending on the region in the Ad DNA.
4. Discussion
In this report, we have shown the interaction of TAF-I with
the Ad DNA through protein VII in early phases of infection.
From the observation that the Ad DNA interacts with protein
VII throughout early phases of infection [8] together with our
observation in this report, it is likely that transcription- and
replication-competent template is composed of DNA^protein
VII^TAF-I complexes.
ChIP assays using anti-TAF-I antibody showed that as the
infection process proceeds, the amount of Ad DNA associated
with TAF-I decreases independent of Ad DNA replication,
while the amount of input DNA remained unchanged prior
to the onset of replication (Fig. 1). It is therefore suggested
that TAF-I and protein VII are dissociated from the Ad
DNA. One of the possible driving forces for dissociation of
TAF-I and protein VII could be the transcription process.
Our assumption is as follows. The structure of the Ad core
is partially remodeled by binding of TAF-I [15] ; as transcrip-
tion factors/machineries could access and bind to DNA, TAF-
I and protein VII may be dissociated; the region free of TAF-
I and protein VII could be more accessible for transcription
Fig. 3. Stoichiometry of TAF-I^protein VII binary complex. A: Na-
tive PAGE analysis of complexes of rTAF and protein VII. rTAF-I
(2.5 Wg) was incubated with protein VII (1/4-, 1/2-, 1-, 2-fold molar
ratio to rTAF-I for lanes 2, 3, 4 and 5, respectively) in a bu¡er con-
taining 20 mM HEPES^NaOH pH7.9, 150 mM NaCl, and 5% glyc-
erol. The mixtures, rTAF-I (lane 1), and protein VII (lane 6) were
subjected to separation on a 7.5% polyacrylamide gel in 0.5UTBE
bu¡er, and proteins were visualized by staining with Coomassie bril-
liant blue. B: Cross-linking assay. The same aliquots as in A were
cross-linked with 0.05% GA at 37‡C for 10 min, and then SDS
sample bu¡er (250 mM Tris^HCl pH 6.8, 40% glycerol and 8%
SDS) was added to stop the cross-linking reaction. The proteins
were separated by a 7.5% SDS^PAGE and visualized by staining
with Coomassie brilliant blue. Bands with a molecular mass more
than 200 kDa could be highly aggregated due to excess cross-link-
ing.
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factors/machineries, thereby being maintained in a transcrip-
tion-active state. This notion may be the case for the pro-
moter region of E1a, one of the immediate-early genes, where
the dissociation of TAF-I and protein VII was signi¢cant
(Fig. 4). The binding of TAF-I may not be enough for other
promoter regions to start transcription, such as the ML pro-
moter region. TAF-I stimulates transcription from the E1a
promoter more e¡ectively than that from the ML promoter
in a cell-free transcription system with nuclear extracts and
the Ad core as template [23]. Nuclease sensitivity assays
showed that TAF-I remodels the E1a promoter region of
the Ad core but less the ML promoter region [15]. Therefore,
not only TAF-I but also other factors and/or processes such
as replication reaction and factors induced by progression of
infection could be required. Earlier studies on the Ad core
structure during the infection [8,24^26] suggest that the Ad
core is rapidly organized into a structure resembling that of
transcription-active cellular chromatin. If so, a question re-
mains whether the remodeled state is kept only by transcrip-
tion factors/machineries or with histones. The histone binding
to the Ad DNA during early phase of infection is still con-
troversial [8,26].
Electrophoretic mobility shift assays revealed that TAF-I
facilitates the release of the free form of DNA and also binds
to the DNA^protein VII complex. Even in the presence of an
excess amount of TAF-I, DNA^protein VII complexes were
not completely disrupted. Since TAF-I mediates both disrup-
tion and assembly of DNA^basic protein complexes [15], we
assume the co-existence of free DNA, protein VII^DNA,
TAF-I^protein VII, and the ternary complexes around the
equilibrium condition.
It is worthwhile to consider the mechanism of the formation
of the ternary complex. The structure of the DNA^protein
VII complex in virions has been studied biochemically and
physicochemically [2,25,27^29], but the precise structure of
the DNA^protein VII complex has not been revealed. The
amino-terminal half and the carboxy-terminal half of protein
VII are rich in basic amino acid residues, and both regions are
suggested to be involved in DNA binding [2,28]. It is sug-
gested that protein VII binds to the phosphate backbone of
DNA [2]. TAF-I has the characteristic acidic tail and forms a
dimer through its amino-terminal region [20]. Two kinds of
the TAF-I^protein VII binary complex can be formed, one
consisting of one TAF-I dimer and one protein VII (complex
A in Fig. 3), and the other of one TAF-I dimer and two
protein VII (complex B in Fig. 3). It is possible to assume
that in complex A each acidic tail in a TAF-I dimer interacts
with each one of two basic regions of protein VII, while in
6
Fig. 4. Distribution of TAF-I on the Ad genome in early phases of
infection. A: The diagram of the location of PCR products on
HAdV-5 DNA detected in B. The arrows show the transcription ini-
tiation sites of HAdV-5. Short bars numbered with 1^10 represent
the location of primer sets used in B, corresponding to lanes 1^10,
respectively. B: Distribution of TAF-I and protein VII on the Ad
DNA. Cell lysates were prepared from cross-linked Ad-infected cells
at 6 h.p.i. as described in the legend for Fig. 1 and Section 2, and
subjected to ChIP analysis with antibodies against TAF-I and pre-
VII. The DNA associated with the immunoprecipitates was semi-
quantitatively analyzed by PCR using primer sets shown in A. Nu-
cleotide sequences of primer sets are as follows: 5P-GGGTC-
AAAGTTGGCGTTTTA-3P and 5P-CAAAATGGCTAGGAGGTG-
GA-3P for the E1a promoter region, 5P-GCTTGGGAGTGTT-
TGGAAGA-3P and 5P-CGGTGTGGAAAAATCCAAAG-3P for the
E1b coding region, 5P-GCATGTTTTCCCTGACCAAA-3P and 5P-
CTGGACGAGCACCGACTACT-3P for the 5000-bp region, 5P-
GCGGTCCTCCTCGTATAGAA-3P and 5P-CCCACCCCCTTTTA-
TAGCC-3P for the ML promoter region, 5P-GCTGGAGCAA-
AACCCAAATA-3P and 5P-TATCTTGCGGGCGTAAAACT-3P for
the ML ORF 52/55-kb region, 5P-CGCAGTGGTCTTACATGCAC-
3P and 5P-CACACGGTTATCACCCACAG-3P for the hexon coding
region, 5P-AGAAGAACATGCCGCAAGAC-3P and 5P-TCGAAG-
GCGAGCTTAAGTGT-3P for the E2b ORF DBP region, 5P-
GCAGCCAGGTGACACTACAG-3P and 5P-AAAGCTGCGTC-
TGCTTTTGT-3P for the E3 ORF region, 5P-TAAAGTAC-
GGGGCTCCTTTG-3P and 5P-GAGGGCCCTGTCCTAGTCTT-3P
for the ML ORF ¢ber region, and 5P-TGGCGTGGTCAAACTC-
TACA-3P and 5P-GATTTTTACAATGGCCGGACT-3P for the E4
ORF region. C: Summary of distribution of TAF-I and protein VII
on the Ad genome. Intensities of the bands in B were measured us-
ing NIH Image from three independent experiments. Intensities of
‘input’, for example, were normalized relative to the maximum in-
tensity among ‘input’ values obtained with various primer sets in
each experiment. The band intensities in ChIP assays with anti-
TAF-I antibody and anti-pre-VII antibody were normalized in a
similar way, and further normalized by each ‘input’ value deter-
mined for each primer set. Normalized values are indicated as bars
with S.D.
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complex B one of the basic regions of protein VII is free from
one TAF-I molecule. Thus, in the ternary complex one of the
basic regions of VII could bind to DNA, the other basic
region being kept bound to TAF-I.
TAF-I binds not only to protein VII but also to pre-VII in
vivo as well as in vitro (unpublished results). This suggests
that TAF-I may play a role(s) in the events of late phases,
such as virion assembly. If pre-VII forms ternary complexes
like protein VII, there could be a mechanism by which ternary
complexes are to be changed to binary complexes, pre-VII^Ad
DNA. Further studies are required in this direction.
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